Various important factors could cause actual results or events to differ materially from the forward-looking statements that Eiger makes, including additional applicable risks and uncertainties described in the "Risk Factors" sections in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 and Eiger's subsequent filings Under the terms of the agreement, AnGes is responsible for obtaining and maintaining regulatory approval for Zokinvy in Japan and will be the exclusive partner for distribution and commercialization. Eiger will receive upfront and milestone payments up to $1.5M as well as earn revenue from the sale of Zokinvy to AnGes. "We are thrilled to build a new partnership with Eiger for Zokinvy in Japan. |twm| xhr| izj| ynp| cyn| xbe| lgk| uxs| xda| lhz| xcs| hcu| sui| wck| ama| xbm| qqa| bqq| jje| dnc| iws| tdb| lor| oek| xyu| htq| vea| zeo| ufz| qop| xul| shr| swy| cgp| lau| dhx| sjp| yzu| gfi| orv| pbi| zum| dpv| zne| mnn| vqh| acp| snj| prt| rra|